- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 123.01M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 125.18M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 138.01M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $30.53M |
| Capex | Q1 2025 · Mar 31, 2025 | $23.38M |
| Capex | Q1 2025 · Mar 31, 2024 | $9.95M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $78.09M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $56.78M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $265.4M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $189.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $529.73M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $481.89M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $586.99M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $554.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.33B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.34B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.86B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.82B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.34 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.39 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.35 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.40 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $52.18M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $51.22M |
| Net Income | Q1 2025 · Mar 31, 2025 | $43.13M |
| Net Income | Q1 2025 · Mar 31, 2024 | $54.34M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $65.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $90.3M |
| Revenue | Q1 2025 · Mar 31, 2025 | $267.29M |
| Revenue | Q1 2025 · Mar 31, 2024 | $300.64M |